Dialco Medical Inc. is a wholly owned subsidiary of Spectral Medical Inc. Founded in March 2019 Dialco is focused on the commercial development of SAMI, its proprietary renal replacement machine (approved for sale by Health Canada and cleared by the FDA). Dialco is attuned to the recent trends in the home hemodialysis (HHD) market and is actively working towards the regulatory development of its HHD machine called DIMI. Dialco is optimistic about it’s future to serve the North American dialysis market. • With SAMI, Dialco Medical offers the healthcare provider an open platform and the flexibility to choose the disposables (dialyzer and “water bags”) to optimize patient treatment while saving costs. In addition, the user-friendly interface can reduce end user training time and expand the adoption of the device in the hospital setting. • With DIMI, Dialco Medical will offer benefits to ESRD patients who perform their dialysis at home (HHD) by providing a user-friendly interface that can keep them connected to the health care provider. Dialco has adopted the slogan, “Your New Partner in Dialysis” to display our willingness to collaborate with various partners to accelerate product adoption with the aim of improving the lives of patients requiring dialysis treatment. To learn more, visit www.dialco.ca and follow us on LinkedIn.